alexa Development Of Vaccines To Control Chlamydia Infection And Disease: Are We Making Any Progress?
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

International Congress on Bacteriology & Infectious Diseases
November 20-22, 2013 DoubleTree by Hilton Baltimore-BWI Airport, MD, USA

Peter Timms
ScientificTracks Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.002
Abstract
Chlamydia trachomatis continues to be the most commonly reported sexually transmitted bacterial infection with more than 100 million new cases diagnosed annually. These acute infections translate into significant downstream health care costs, particularly for women, where infertility and pelvic inflammatory disease are the most serious sequaele. While it is accepted that a successful vaccine should preferably reduce infection levels to below that required for transmission, a vaccine that can prevent the adverse pathology is also required. Our laboratory has used the mouse/C. muridarum model to show that, using the major outer membrane protein, MOMP as the vaccine candidate, subcutaneous, transcutaneous, intranasal, oral and even sublingual routes of administration all result in significantly reduced infection burdens, reduced length of infection and most importantly, reduced pathology in the upper genital tract. Recent results however are showing that the vaccine preparation that produces the best reduction in infectious load does not necessarily result in the best reduction in pathology score. The key cytokine responses that underpin each type of protection are now beginning to be elucidated. The mouse/C. muridarum model has a weakness in that it is not a natural infection model. Work with a multi-MOMP vaccine against natural C. pecorum infections in the koala model is showing considerable promise and may point to key differences between natural immunity and vaccine induced immunity. Overall, while still remaining a major challenge, the development of a successful C. trachomatis vaccine is starting to look more likely.
Biography
Peter Timms is Professor of Microbiology and director of research at QUT?s Institute of Health and Biomedical Innovation in Brisbane Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. He has published over 170 refereed journal papers and is editor of the journal, Pathogens and Disease.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords